Duncan Richards

Today, we formally welcome Professor Duncan Richards as the new Director to OCTRU, replacing Professor Sarah (Sallie) Lamb who, together with Professor Doug Altman founded the CTU back in 2012. 

Professor Richards, an Oxford-trained clinician, joins OCTRU from his previous roles as Head of Clinical Pharmacology and Experimental Medicine at GSK, and Research Director of GSK’s phase 1 and experimental medicine unit in Cambridge (CUC).

Professor Lamb is moving to a new role at Exeter University, but will continue as Strategic Lead for OCTRU’s Rehabilitation Research group. 

Members of the unit are looking forward to the continued evolution of OCTRU under Professor Richards, building on its reputation as a firmly established CTU conducting numerous clinical trials across all phases and areas of medicine. Professor Richards said: ‘In my short time in Oxford I have been tremendously impressed by the breadth and quality of work undertaken by OCTRU and its partners. I would like to pay tribute Sallie and the team for building a robust but flexible organisation that is ready to take on new challenges and opportunities as the clinical trials portfolio continues to evolve.’

Similar stories

AVID-CC trial opens to recruitment!


The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research Trauma

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

WHiTE Four trial results!


The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!


The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!


The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand


Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.